LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
Scale AI’s Massive Funding Boost What This Means for the Future of AIBy News Team22/05/2024 Scale AI has recently secured a colossal $1 billion in Series F funding, propelling its valuation to a staggering $14 billion. This achievement is not just…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
